Understanding, mitigating and managing vaccination reactogenicity

1. Hervé C, Laupèze B, Del Giudice G, et al. The how's and what's of vaccine reactogenicity. NPJ Vaccines 2019;4:39.

2. Petousis-Harris H. Vaccine injection technique and reactogenicity--evidence for practice. Vaccine 2008;26(50):6299–304.

3. Petousis-Harris H, Poole T, Stewart J, et al. An investigation of three injections techniques in reducing local injection pain with a human papillomavirus vaccine: a randomized trial. Vaccine 2013;31(8):1157–62.

4. The Immunisation Advisory Centre. Mitigating vaccination pain and distress. 2016. https://www.immune.org.nz/resources/written-resources

5. Ministry of Health. Immunisation Handbook 2020. Wellington, NZ: Ministry of Health; 2020. https://www.health.govt.nz/publication/immunisation-handbook-2020

6. Das RR, Panigrahi I, Naik SS. The effect of prophylactic antipyretic administration on post-vaccination adverse reactions and antibody response in children: a systematic review. PLoS One 2014;9(9):e106629.

7. Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 2020;383(27):2603–15.

8. AusVaxSafety. COVID-19 vaccine safety surveillance. 1 August 2021. https://www.ausvaxsafety.org.au/safety-data/covid-19-vaccines